Immucell(DE:IUL)
€9.00+0.20 (+2.27%)
DE:IUL
Immucell Revenue
€9.00
At close:+0.20 (+2.27%)
Immucell (IUL) Revenue
1 Followers
Immucell Revenue
Immucell had a revenue of 7.19M in the quarter ending Jun 30, 2026, with -30.62%. This bring the company's revenue in the last twelve months to 30.68M, Increased 2.48%. In the fiscal year ending Dec 31, 2025, Immucell had annual revenue of 27.64M with 4.34% growth.
- Revenue (ttm)
- 30.68M
- Revenue Growth
- 0.79%
- P/S Ratio
- 3.04
- Revenue/Employee
- EUR 378,687
- Employees
- 73
- Market Cap
- EUR 83.97M
Revenue Chart
Immucell Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.64M | 1.15M | 4.34% |
| Dec 31, 2024 | 26.49M | 9.02M | 51.64% |
| Dec 31, 2023 | 17.47M | -1.10M | -5.90% |
| Dec 31, 2022 | 18.57M | -674.97K | -3.51% |
| Dec 31, 2021 | 19.24M | 3.90M | 25.43% |
| Dec 31, 2020 | 15.34M | 1.62M | 11.80% |
| Dec 31, 2019 | 13.72M | 2.74M | 24.91% |
| Dec 31, 2018 | 10.99M | 555.00K | 5.32% |
| Dec 31, 2017 | 10.43M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.